Related Experiment Video
Updated: Jun 4, 2025

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Identification of G protein subunit alpha i3 as a promising oncotarget of LUAD
Gaomeng Luo1, Wenxuan Hu1, Jian Yang1
1Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Abstract:
Exploring new oncotargets essential for lung adenocarcinoma (LUAD) cell growth is important. Here the bioinformatical studies revealed that Gαi3 expression is elevated in LUAD tissues and its overexpression correlates with poor survival of the patients. Moreover, overexpression of Gαi3 mRNA and protein was detected in LUAD tissues of patients as well as in primary/immortalized LUAD cells. In both primary and immortalized LUAD cells, genetic silencing (by viral shRNA) or knockout ("KO", through CRISPR/Cas9 method) of Gαi3 potently inhibited LUAD cell proliferation and mobility. The results of caspase-3 activity assay, caspase-9 activity assay, histone DNA ELISA, TUNEL nuclear staining and Annexin V staining showed that inhibition of Gαi3 expression promoted apoptosis. In addition, a significant decrease in mitochondrial membrane potential was found in Gαi3-deficient LUAD cells by JC-1 staining. Overexpression of Gαi3 strengthened the proliferation and migration of LUAD cell. Gene set enrichment analysis revealed that Gαi3 was closely related to PI3k/Akt/mTOR, which we validated experimentally. Akt-S6K phosphorylation was downregulated following Gαi3 silencing or KO, but augmented after Gαi3 overexpression in primary LUAD cells. Restoring Akt-S6K phosphorylation by a S473D constitutively-active mutant Akt1 ameliorated Gαi3 KO-induced LUAD cell proliferation inhibition, migration suppression and apoptosis. In vivo, the growth of subcutaneous LUAD xenografts was largely inhibited after intratumoral injection of Gαi3 shRNA-expressing adeno-associated virus (AAV). Gαi3 downregulation, Akt-mTOR inhibition, proliferation inactivation and apoptosis were detected in the Gαi3 shRNA-treated LUAD xenografts. Together, targeting Gαi3 potently inhibited LUAD cell growth in vitro and in vivo.
Insights
Targeting G-protein alpha-i3 (Gαi3) inhibits lung adenocarcinoma (LUAD) growth. Gαi3 overexpression drives LUAD cell proliferation and migration, while its silencing promotes apoptosis and reduces tumor growth in vivo.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Lung adenocarcinoma (LUAD) cell growth requires identification of novel therapeutic targets.
- G-protein alpha-i3 (Gαi3) is upregulated in LUAD and linked to poorer patient survival.
Purpose of the Study:
- To investigate the role of Gαi3 in LUAD progression and evaluate its potential as a therapeutic target.
Main Methods:
- Bioinformatical analysis of LUAD tissues.
- Genetic manipulation of Gαi3 expression using shRNA and CRISPR/Cas9.
- Assays for cell proliferation, migration, apoptosis, and mitochondrial membrane potential.
- Western blotting and gene set enrichment analysis to explore signaling pathways.
- In vivo xenograft models.
Main Results:
- Gαi3 overexpression correlates with poor LUAD patient survival.
- Gαi3 silencing or knockout inhibits LUAD cell proliferation, migration, and induces apoptosis.
- Gαi3 regulates LUAD cell functions via the PI3K/Akt/mTOR pathway.
- In vivo, Gαi3 downregulation via AAV-shRNA suppressed xenograft tumor growth.
Conclusions:
- Gαi3 is a critical driver of LUAD progression.
- Targeting Gαi3 represents a promising therapeutic strategy for lung adenocarcinoma.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Activation and Inactivation of G Proteins
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Targeted Cancer Therapies
There are several types of targeted therapies against...
lncRNA - Long Non-coding RNAs
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
IP3/DAG Signaling Pathway